DCs, clinical experts echo similar views in support of HCQ as COVID 19 drug with clarification of no cardiotoxicity in RA patients

pharmabiz.com – With hydroxychloroquine (HCQ) being preferred as the first line of treatment for COVID-19 patients and state drug controllers ensuring its adequate availability in the wake of rising COVID-19 cases, …



Source: HCQ News, DCs, clinical experts echo similar views in support of HCQ as COVID 19 drug with clarification of no cardiotoxicity in RA patients

Leave a Reply

Your email address will not be published. Required fields are marked *